2020 United States

Description

MSACL 2020 US
12^th Annual Conference & Exhibits

The Riviera Hotel

Palm Springs, CA

March 29 - April 2, 2020

April 3, 2020 : Dedicated IMSS Programming

Program Description

MSACL provides a forum for discussing the clinical application of mass spectrometry by bringing together academic and industrial experts in the field with those driven to explore and understand more about the potential application and benefits. The mission of MSACL is to accelerate the implementation of mass spectrometry in the clinical laboratory with the goal of contributing to the improvement of patient standard- of-care as well as reducing health care costs. MSACL is happy to announce that we have partnered with the Imaging Mass Spectrometry Society (IMSS) to provide the IMS community an opportunity to share and collaborate with the members of the clinical mass spectrometry community.

Scientific Program Highlights

1. Plenary & Keynote Sessions

Distinguished Contribution Award Lecture
		My Path to Enlightenment, or How I Became a Clinical Mass Spectrometrist and Clinical Chemist Alan Rockwood Professor Emeritus, University of Utah
Plenary Lectures
		Comprehensive Mapping of Cell Lineage and Function in Human Tissue Using MIBI-TOF Michael Angelo Stanford Bio-X
		Brain Organoids as a Model System for Human Neurodevelopment and Evolution Alysson Muotri University of California, San Diego
Keynote Lectures
		Olga Vitek Northeastern University
		Lingjun Li University of Wisconsin-Madison
		Chip Cody JEOL
		mcr and VCA – two R packages to facilitate your method comparison and precision studies Andrea Geistanger Roche
		Michael Lassman Merck
		Tom Rosano Albany Medical College
		Spatial Metabolomics: From Big Data to Single Cells Theodore Alexandrov European Molecular Biology Laboratory - Heidelberg
		Catherine Costello Boston University School of Medicine
		Jonathan Sweedler University of Illinois at Urbana-Champaign

2. Scientific Sessions :: Submit an Abstract
> > cutting edge science in areas of clinical chemistry and diagnostics

3. Scientific Posters :: Submit an Abstract
> > a chance for you to present your research & see the work of others

Educational Program

1. Short Courses
> > in-depth training in specific areas of expertise

2. Practical Training Sessions
> > lectures and interactive sessions on clinical mass spectrometry fundamentals and troubleshooting cases.
> > Planned MSACL 2020 US Practical Training Sessions (Subject to change):

1. Transition Ratio Monitoring for the Masses (Russ Grant)
   
2. Taking Aim at Analytical Interference in LC-MS (Without Shooting Yourself in the Foot)​ (Zlata Clark)
   
3. System Suitability and Real-Time Quality Control using Skyline and Panorama (Will Thompson, Chris Shuford, Mike MacCoss)
   
4. Working Smarter not Harder on Sample Prep (Matt Crawford)
   
5. Free Climb or Free Solo: Guidance and accounts of establishing reference intervals for LDT mass spectrometry assays (Elizabeth Frank, Kelly Doyle)
   
6. What Do You Do When Your Good Assay Goes Bad? (Sarah Shugarts, Howard Horng)
   
7. R-showcase (Shannon Haymond)
   
8. Mastering Mass Spectrometry in the Clinic - Cases and Chronicles (Hema Ketha, Jen Colby)

3. Troubleshooting Poster Rounds :: Submit an Abstract
> > a chance to present your method problems and fixes, and learn from others

4. Vendor Workshops
> > an opportunity to learn about the latest offerings and great science being done by our industry colleagues

Educational Grants

MSACL invests heavily in education via the MSACL Educational Grants, which support conference attendance:

1. Surgical Pathologist Grants: Surgical Pathologists interested in learning more about what mass spectrometry is and how it could potentially improve their workflow must submit a short application.
2. Young Investigator Grants: Young investigators, in the first four years of their academic position, who submit an abstract which is accepted for presentation (poster/podium) at the annual conference. Applicants must submit a short application.
3. Lab Director Grants: Lab Directors interested in learning more about what mass spectrometry is and how it could potentially improve results and reduce costs in their clinical laboratory are not required to submit an abstract, but must submit a short application.
4. Trainee Grants: Lab Directors-to-be interested in learning more about what mass spectrometry is and how it could potentially improve results and reduce costs in their clinical laboratory are not required to submit an abstract, but must submit a short application.

Scientific Program Tracks

It's the abstracts that make the meeting. Are you working in clinical mass spectrometry and have compelling results that you want to present at the most focused clinical mass spec meeting in the world? Submit your abstract for the MSACL Conference.

A comprehensive list of the topics being solicited for the current conference is below.

Abstract Submission Categories for MSACL 2020 US

*Note: Abstracts are solicited for the topics listed below, however, if no abstracts are submitted and accepted on any given topic then it will not be covered at the conference.

1. Breath Analysis and VOC
2. Cases in Clinical MS
3. Data Science
4. Glycomics
5. Imaging
6. IMSS Special Topics
7. Lipidomics
8. Metabolomics
9. Microbiology
10. Natural Products / Environmental
11. Practical Training
12. Proteomics
13. Tox / TDM / Endocrine
14. Troubleshooting
15. Various OTHER

Target Audience

The target audience for this program includes pathologists, clinical laboratory directors and scientists, mass spectrometry and automated sample processing providers as well as laboratory diagnostic providers. This program will be beneficial to healthcare administrators, laboratory quality control and standards scientists, as well as those responsible for implementation of clinical analyses for emergency response due to terrorism or accident.

Needs Assessment

This meeting will be critical to share emerging analytical information and work concerning regulations and standards. The goal of MSACL is to create an environment through which participants will be able to identify opportunities to develop the capacity to provide higher quality results, more rapidly and for lower overall cost, for patients within the healthcare system.